Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Internal Medicine
Volume 21 (2024): Issue 1 (March 2024)
Open Access
The Role of GLP 1 Receptor Agonists in Treating Heart Failure: Useful or Not?
Laura Lungeanu-Juravle
Laura Lungeanu-Juravle
,
Andra Nica
Andra Nica
,
Emilia Rusu
Emilia Rusu
and
Gabriela Radulian
Gabriela Radulian
| Mar 29, 2024
Internal Medicine
Volume 21 (2024): Issue 1 (March 2024)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Mar 29, 2024
Page range:
39 - 47
DOI:
https://doi.org/10.2478/inmed-2024-0276
Keywords
heart failure (HF)
,
diabetes mellitus type 2 (T2DM)
,
Glucagon-like peptide-1 receptor agonists (GLP-1 Ras).
© 2024 Laura Lungeanu-Juravle et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Laura Lungeanu-Juravle
Department of Cardiology - Clinical Hospital “Nicolae Malaxa”,
Bucharest, Romania
Andra Nica
“Carol Davila” University of Medicine and Pharmacy
Bucharest, Romania
Emilia Rusu
“Carol Davila” University of Medicine and Pharmacy
Bucharest, Romania
Gabriela Radulian
“Carol Davila” University of Medicine and Pharmacy
Bucharest, Romania